Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Parkinson's Disease
94%
Luxembourg
70%
COVID-19
57%
Parkinson
48%
Health Institutes
42%
Recherche
35%
Mild Cognitive Impairment
28%
Levodopa-induced Dyskinesia
28%
Severe Acute Respiratory Syndrome
28%
Idiopathic Parkinson's Disease
28%
Vaccine Effectiveness
28%
Essais
25%
Europe
22%
95% Confidence Interval
19%
Machine Learning
18%
Clinical Data
17%
Hospitalization
17%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
17%
Colorectal Cancer
17%
Polygenic Risk Score
17%
Laboratory Confirmation
17%
Clinical Treatment
17%
Gut Microbiota
17%
Risk Factors
16%
Luxembourgish
15%
GBA1
15%
ECRIN
14%
Gut Metabolites
14%
Disease Effects
14%
Coronavirus Disease (COVID)
14%
Householder
14%
Prospective Longitudinal Cohort
14%
Cardiovascular History
14%
Prognostic Analysis
14%
Risk Variant
14%
Multi-country Study
14%
Disease Duration
14%
Dopaminergic Pathway
14%
Long-read Sequencing
14%
Acknowledgment
14%
Impulse Control Disorders
14%
IL-1R1
14%
Domaining
14%
Consentement
14%
Vaccin
14%
Disease Severity
14%
Cross-cohort
14%
Authorship Criteria
14%
Outcome Prediction
14%
Gait Data
14%
Metabolomics Data
14%
Clinical Decision Support Tool
14%
Colorectal Cancer Progression
14%
Pratique
14%
Meta-analysis
14%
Clinical Oncology
14%
Personalized Interventions
14%
Healthy Lifestyle Behaviors
14%
Comprehensive Program
14%
Antiviral Drugs
14%
Memory Impairment
14%
Recurrent Glioblastoma
14%
Repurposing
14%
Cognitive Impairment Diseases
14%
Health Effects
14%
Healthy Adults
14%
Metabolism
14%
Interim Analysis
14%
Social Determinants of Mental Health
14%
Lopinavir
14%
Functional Profiling
14%
Carrot
14%
Post-COVID
14%
Control Obesity
14%
Whey Protein Isolate
14%
Tumor Immunosuppression
14%
Soy Protein Isolate
14%
Tumor Development
14%
Digital Health Strategies
14%
Aging Effect
14%
Older Adults
14%
Patient-derived Spheroids
14%
Recommendation System
14%
Polygenic Background
14%
Cardiovascular Risk
14%
Xanthine Metabolism
14%
Predictors of Cognitive Impairment
14%
Formate
14%
Healthy Lifestyle
14%
Therapeutic Response
14%
Idiopathic PD
14%
Variant Carriers
14%
Interferon-α (IFN-α)
14%
Cancer-associated Fibroblasts
14%
Trial Results
14%
Major Risk
14%
HT-29
14%
Tomato Juice
14%
Metastatic Colorectal Cancer (mCRC)
14%
Age of Onset
14%
Medicine and Dentistry
Parkinson's Disease
100%
COVID-19
78%
Malignant Neoplasm
35%
Gait
34%
Diseases
31%
Metabolomics
31%
Prevalence
29%
Arteriosclerosis
28%
Red Wine
28%
Lifestyle Modification
28%
Mild Cognitive Impairment
28%
Education
27%
Physical Activity
26%
Severe Acute Respiratory Syndrome Coronavirus 2
24%
Public Health
24%
Comorbidity
22%
Cohort Effect
21%
Digital Health
21%
Early Diagnosis
21%
Medical Examination
21%
Infection
20%
Health Status
19%
Cohort Analysis
19%
Booster Dose
19%
Gut Microbiome
16%
Healthy Lifestyle
16%
Atypical Parkinsonism
16%
Colorectal Carcinoma
15%
Biological Marker
15%
Clinical Research
14%
Respiratory Tract Infection
14%
Randomized Controlled Trial
14%
Disease Severity
14%
Arterial Pressure
14%
Cardiovascular Risk
14%
Clinical Oncology
14%
Alzheimer's Disease
14%
Respiratory Disease
14%
Omicron Coronavirus Variant
14%
Observational Study
14%
Multipartite
14%
Blood Flow Velocity
14%
Biomedical Research
14%
Artery Blood Flow
14%
Middle Cerebral Artery
14%
Virus
14%
Precision Oncology
14%
Treatment Response
14%
Metastatic Colorectal Cancer
14%
Tumor Spheroid
14%
HT-29 Cell Line
14%
Metabolite
14%
Cancer Growth
14%
RNA Sequence
14%
Formic Acid
14%
Dopamine
14%
Levodopa-Induced Dyskinesia
14%
Cardiovascular System
14%
Gut
14%
Glucagon Like Peptide 1
14%
Drug Therapy
14%
Primary Prevention
14%
Genetics
13%
Artificial Intelligence
12%
Brain Blood Flow
12%
Neoplasm
11%
Cardiovascular Disease
10%
Messenger RNA
10%
Diabetes
10%
Personalized Medicine
10%
Clinical Trial
9%
Carotid Atherosclerosis
8%
Cognitive Defect
8%
Mediterranean Diet
8%
Design Controls
7%
Volunteer
7%
Immune System
7%
Degenerative Disease
7%
Middle Age
7%
Cardiometabolic Risk
7%
Hypertension
7%
Stereotypic Movement Disorder
7%
Prophylaxis
7%
Effective Treatment
7%
Onset Age
6%
Unified Parkinson's Disease Rating Scale
6%
Levodopa
6%
Statin
6%
Progressive Supranuclear Palsy
5%
Drug Response
5%
Transcriptomics
5%
Psychological Well-Being
5%
Health Care
5%
Tumor
5%
Genome Sequencing
5%
Cross-Validation
5%
Anthropometry
5%
Obesity
5%
Lipid
5%
Health Outcomes
5%